
The past decade has seen a large change in the field of pharmacy, with many companies changing the landscape with new mergers and acquisitions.
Timothy Dy Aungst, PharmD, is an associate professor of pharmacy practice at MCPHS University. He graduated from Wilkes University Nesbitt School of Pharmacy and completed a PGY-1 Pharmacy Practice Residency at St. Luke's University Hospital, and then a Clinical Geriatric Fellowship at MCPHS University. He is passionate about the rise of technology in health care and its application to pharmacy. He has published primarily on the role of mobile technology and mHealth, and made multiple national and international presentations on those topics. He blogs at TheDigitalApothecary.com, is a Co-Host of FurtureDose.tech a podcast part of the Pharmacy Podcast Network, and you can find him on Twitter @TDAungst.
The past decade has seen a large change in the field of pharmacy, with many companies changing the landscape with new mergers and acquisitions.
Looking to get their data into clinician hands, Higi has teamed up with Rush to get their data into institutions using Epic's EHRs.
More smart inhalers are coming to the US market and pharmacists may see them soon.
Getting to your medical appointment can be a pain, so why not call on Uber or Lyft? Well, soon you'll get your chance.
Technology is great when it works, but in this case, the issue of recieving the wrong amount of insulin can be problematic.
With new smartphones able to measure blood pressure, what does this mean for other companies who solely make these devices?
Can home voice assistants be the future of medication management in the near future?
A recent pilot looked into whether using a personal robot in a patients home could prevent readmission rates for those recently hospitalized with COPD.
What if Google Maps was powered to help patients navigate to their appointments quicker? Can Uber be a solution for transportation? New research sheds some light on these possibilities.
With Apple eyeing up the EHR space, the rational movement to get patients data through their iPhones is just the next place to start.
Natural Cycles is a EU-cleared application to help women avoid pregnancy, but recently there have been some concerns about how well it works.
Could giving patients money help improve their adherence? Mount Sinai is currently piloting a new platform to find out.
CVS and other companies want pharmacists to be performing POC, so should you be getting that training?
What else can a parent do to track their child's fever in real time, aside from a standard thermometer? Well, there is a new slew of wearables that have come onto market worth considering.
Aside from sunscreen, what other tools could pharmacists recommend for patients to limit their sun exposure?
Chemotherapy is difficult, and in children even more so. Sproutel has teamed up with Aflac to create a companion robot to help children undergo chemotherapy easier.
A new company has a breast pump that many pharmacists may find valuable to use at work compared to what is currently on the market.
A new company aims to help people get their supplements through the water bottle instead of just taking pills.
A new company offers an interesting solution to helping patients remember to take their birth control.
Now that Eli Lilly is looking to create a closed-loop system for diabetes management, does that mean this product will soon be available?
A look at how the digital landscape could change after a merger between an insurer and giant retail pharmacy company is finalized.
Hacking the brain to work better and faster has been a hot topic, but research shows that nootropics products may fall short.
Seeing a doctor usually means making an appointment weeks in advance or going to a walk-in clinic, but Forward is different.
New Hampshire is seeking to join the list of states allowing pharmacists to provide contraception to women without a prescription.
Apple announces a study to investigate whether their Apple Watch can detect afib in patients.
Currently, the plan is to role out Viagra Connect in the first or second quarter of 2018.
While Proteus and Otsuka's recently-FDA approved smart pill is making big news, there are other start-ups making some strides into the market.
The retail pharmacy and health care company will bring prescriptions to patients' doors in select cities, but this raises several questions.
What do pharmacists need to know about these mobile applications recently approved by the FDA?
Does this represent an opportunity for pharmacists to use such devices to help monitor adherence in patients?